Opinion: China’s Firms Could End Up Trapped Between U.S. Law, Beijing
Facing a $147 million claim in U.S. courts, two Chinese vitamin C manufacturers argued in a brief filed before the U.S. Supreme Court last week that they should not be punished for following an explicit directive from the Chinese Ministry of Commerce (MOFCOM).
MOFCOM has also requested to participate in the oral argument in support of the Chinese companies, which would mark the first time in history that the Chinese government has appeared before the U.S. Supreme Court. In its request, MOFCOM reconfirmed that Chinese regulations compelled the actions of the Chinese manufacturers. For the other side, claimants argued — with support from the U.S. Department of Justice — that U.S. courts are not required to defer absolutely to the Chinese government’s interpretation of Chinese law or regulations. The court’s ruling — expected in June — is likely to have an enormous impact on the way Chinese companies make business decisions regarding U.S. markets.
- 1Update: China Demands Answers for Swedish Police’s ‘Brutal’ Treatment of Tourists
- 2Chinese Thesis Ghostwriting Scandal Reveals Huge Gray Market
- 3China Could Ban Exports of Products Crucial to U.S. Manufacturers, Former Finance Minister Says
- 4 State-Owned Firms to Build $6.5 Billion Petrochemical Refinery in Alberta
- 5Trump Slaps New Tariffs on $200 Billion of Chinese Goods
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas